Delivra's current pharmaceutical offerings as per page 7 of their investor slide deck.

Friday, May 9, 2025

Latest

Beijing Finally Agrees to Talk Trade with Washington

B2Gold Q1 2025: Cash Flow Crashes 75% Despite 50% Profit Jump

Trump to Scrap Biden-Era Global AI Chip Curbs

Gates-Bezos Mining Venture Plans Entry into Congo’s Contested Lithium Sector

BREAKING: Habemus Papam! Conclave Elects First American Pope To Lead 1.4B Catholics

Spain Reconsiders Nuclear Phase-Out After Grid Collapse

Orsted Pulls Plug on Massive Hornsea 4 Wind Farm, Citing Economic Pressures

US Leverages Trade Talks to Push Starlink Expansion, Documents Show

BREAKING: Trump Announces Expanded Market Access In First Post-Tariff Deal With UK

Shopify’s Q1 2025 Net Loss Swells 150%, Undermining Revenue and Cash Flow Gains

Delivra’s current pharmaceutical offerings as per page 7 of their investor slide deck.

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.